| Dr Kadian Bennett, PHARMD | |
|
4030 Annas Retreat, Charlotte Amalie, VI 00802-2221 | |
| (340) 777-9255 | |
| Not Available |
| Full Name | Dr Kadian Bennett |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 4030 Annas Retreat, Charlotte Amalie, Virgin Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033760368 | NPI | - | NPPES |
| PS52183 | Other | FL | APHA |
| 359 | Other | VI | VIRGIN ISLANDS PHARMACIST LICENSE |
| 50-3800 | Other | APHA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 359 (Virgin Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kadian Bennett, PHARMD 4030 Annas Retreat, Charlotte Amalie, VI 00802-2221 Ph: (340) 777-9255 | Dr Kadian Bennett, PHARMD 4030 Annas Retreat, Charlotte Amalie, VI 00802-2221 Ph: (340) 777-9255 |
News Archive
Researchers at Northwestern Memorial have launched the first-ever National Institutes of Health-sponsored clinical trial for spinal deformity. The trial will evaluate the effectiveness of surgical and non-surgical treatments in people with adult scoliosis or curvature of the spine. Researchers also hope to identify important factors related to patient reported outcomes such as pain, activity and appearance.
Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.
Zeiss LSM 780 laser scanning microscope provides high resolution and fast imaging for studies on neuronal structure, function, and neuro development.
Medunik Canada, a Canadian pharmaceutical company specialized in rare diseases, is pleased to announce that PHEBURANE (a tasteless oral formulation of sodium phenylbutyrate), is now available for distribution in Canada. PHEBURANE is the first drug to be approved in Canada for the chronic management of urea cycle disorders (UCD) after receiving market authorisation on January 27th, 2015.
Olfactory function is preserved in about a quarter of patients with Parkinson's disease, and may be predictive of disease course, say researchers.
› Verified 1 days ago
Dr. Kelly Edens, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6f Estate Thomas New Quarter Bldg 4, Charlotte Amalie, VI 00802 Phone: 340-776-1235 |